Topics

Anxiety, Alzheimer's Tx Flops; Suicidal Ideation in Kids, Too

10:00 EST 12 Feb 2020 | MedPageToday

]]>(MedPage Today) -- Biohaven's investigational anxiety treatment troriluzole failed in an 8-week phase III trial. Two investigational Alzheimer's disease treatments -- Eli Lilly's solanezumab and Roche's gantenerumab -- both flopped in trials...

Original Article: Anxiety, Alzheimer's Tx Flops; Suicidal Ideation in Kids, Too

NEXT ARTICLE

More From BioPortfolio on "Anxiety, Alzheimer's Tx Flops; Suicidal Ideation in Kids, Too"

Quick Search

Relevant Topics

Anxiety Disorders
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of everyday situations. The most common types of anxiety di...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...